Quinidine dosage, with special reference to an oral loading dose schedule

Area of Science:

• Pharmacology
• Cardiology
• Clinical Pharmacy

Background:

• Quinidine is an antiarrhythmic drug used to treat cardiac conditions.
• Optimizing quinidine dosing is crucial for efficacy and safety.
• Understanding plasma concentration dynamics is key for therapeutic management.

Purpose of the Study:

• To analyze plasma quinidine concentrations in cardiac patients.
• To evaluate different oral loading and maintenance dosage regimens.
• To compare conventional and sustained-release quinidine preparations.

Main Methods:

• Plasma quinidine levels were measured in 52 cardiac patients.
• Oral loading doses and maintenance dosage intervals were varied.
• Both conventional and sustained-release quinidine formulations were used.

Main Results:

• Most patients achieved therapeutic plasma quinidine concentrations (2-4 microgram/ml) within 3 hours post-loading dose.
• A 12-hour maintenance interval with sustained-release tablets showed acceptable drug fluctuations, similar to an 8-hour interval.
• Significant individual variations in plasma quinidine concentrations were observed.

Conclusions:

• Rapid achievement of therapeutic quinidine levels is possible with appropriate loading and maintenance strategies.
• Sustained-release quinidine allows for flexible dosing intervals (e.g., 12 hours) without compromising therapeutic control.
• Therapeutic drug monitoring of plasma quinidine concentrations is essential due to inter-individual variability.